Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Valve repair system still performing well | CV complications & male breast cancer | An effective treatment for HCM
Tuesday, January 26, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

PASCAL valve repair system still performing well for TR patients after 30 days

Overall, researchers wrote in the Journal of the American College of Cardiology, the PASCAL repair system has been working as it was intended.

READ MORE >
Even patients who were never hospitalized for COVID-19 face a heightened risk of cardiovascular issues. #longcovid
Share on Twitter Share on Facebook Share on Linkedin

PASCAL valve repair system still performing well for TR patients after 30 days

Share on Twitter Share on Facebook Share on Linkedin
Even patients who were never hospitalized for COVID-19 face a heightened risk of cardiovascular issues. #longcovid
Overall, researchers wrote in the Journal of the American College of Cardiology, the PASCAL repair system has been working as it was intended.
READ MORE >

Male breast cancer patients face a heightened risk of cardiovascular issues

The new findings are part of a virtual conference being hosted by the American College of Cardiology. 

READ MORE >
Heart failure hospitalizations among young adults are getting more common and more expensive
Share on Twitter Share on Facebook Share on Linkedin

Male breast cancer patients face a heightened risk of cardiovascular issues

Share on Twitter Share on Facebook Share on Linkedin
Heart failure hospitalizations among young adults are getting more common and more expensive
The new findings are part of a virtual conference being hosted by the American College of Cardiology. 
READ MORE >

AFib ablation is effective for HCM patients, leading to long-term rhythm control

Overall, 60% of patients demonstrated complete freedom from recurrences of atrial fibrillation or atrial tachycardias.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

AFib ablation is effective for HCM patients, leading to long-term rhythm control

Share on Twitter Share on Facebook Share on Linkedin
Overall, 60% of patients demonstrated complete freedom from recurrences of atrial fibrillation or atrial tachycardias.
READ MORE >

Featured Articles

Higher hospitalization rates for chest pain do not lead to better outcomes

Chest pain is one of the most common reasons adults in the United States visit the emergency department, leading to more than 7 million patient encounters each year.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Higher hospitalization rates for chest pain do not lead to better outcomes

Share on Twitter Share on Facebook Share on Linkedin
Chest pain is one of the most common reasons adults in the United States visit the emergency department, leading to more than 7 million patient encounters each year.
READ MORE >

Merck’s vericiguat gains FDA approval for treating high-risk chronic heart failure patients

Sold as Verquvo, the medication can help patients reduce their risk of cardiovascular death or hospitalization for heart failure.

READ MORE >
approved approval
Share on Twitter Share on Facebook Share on Linkedin

Merck’s vericiguat gains FDA approval for treating high-risk chronic heart failure patients

Share on Twitter Share on Facebook Share on Linkedin
approved approval
Sold as Verquvo, the medication can help patients reduce their risk of cardiovascular death or hospitalization for heart failure.
READ MORE >

Diabetes, insulin resistance strongly associated with premature coronary heart disease among women

The study’s authors explored data from more than 28,000 women, focusing on the impact of dozens of biomarkers. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Diabetes, insulin resistance strongly associated with premature coronary heart disease among women

Share on Twitter Share on Facebook Share on Linkedin
The study’s authors explored data from more than 28,000 women, focusing on the impact of dozens of biomarkers. 
READ MORE >

TAVR in the time of COVID-19: Providers quickly adapted, delivering ‘excellent’ outcomes

Researchers compared patient outcomes from 2019 with data from the pandemic’s first four months, sharing their findings in the American Journal of Cardiology.  

READ MORE >
Hypertension patients measured their blood pressure less frequently during the early months of the COVID-19 pandemic, according to new research published in Hypertension. In addition, when those patients did measure their blood pressure, the readings were less healthy than they had been before the pandemic.
Share on Twitter Share on Facebook Share on Linkedin

TAVR in the time of COVID-19: Providers quickly adapted, delivering ‘excellent’ outcomes

Share on Twitter Share on Facebook Share on Linkedin
Hypertension patients measured their blood pressure less frequently during the early months of the COVID-19 pandemic, according to new research published in Hypertension. In addition, when those patients did measure their blood pressure, the readings were less healthy than they had been before the pandemic.
Researchers compared patient outcomes from 2019 with data from the pandemic’s first four months, sharing their findings in the American Journal of Cardiology.  
READ MORE >

From the Magazine

ENJOY THE GLIDE More Retirement Glide-paths Means Wins for Everyone

Some cardiologists vow to go out with their scrubs on, says St. Vincent Heart Center’s Mary Norine Walsh, MD, as she recalls an interventional cardiologist who declared that when he left the cath lab, he’d be gone for good, not doing “office work.”

READ MORE >
Enjoy The Glide
Share on Twitter Share on Facebook Share on Linkedin

ENJOY THE GLIDE More Retirement Glide-paths Means Wins for Everyone

Share on Twitter Share on Facebook Share on Linkedin
Enjoy The Glide
Some cardiologists vow to go out with their scrubs on, says St. Vincent Heart Center’s Mary Norine Walsh, MD, as she recalls an interventional cardiologist who declared that when he left the cath lab, he’d be gone for good, not doing “office work.”
READ MORE >

In Other News

Going by online browsing patterns, telehealth will remain a force after COVID

Google searches for “telehealth” have fallen far since peaking in March 2020. However, the term is plateauing at a rate that’s 320% higher than in pre-pandemic times.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Going by online browsing patterns, telehealth will remain a force after COVID

Share on Twitter Share on Facebook Share on Linkedin
Google searches for “telehealth” have fallen far since peaking in March 2020. However, the term is plateauing at a rate that’s 320% higher than in pre-pandemic times.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Week in Review: Americans keep poisoning themselves | Device recalled over safety concerns | ACC takes on antiplatelet therapies
AI works behind the scenes | CCTA scan delivers wake-up call | The future of FFR-CT | Subtle heart changes linked to cancer risk
Looking Back: Is coffee bad for the heart? | Procedure kit recalls | Cardiologist gets wake-up call | TAVR policy changes
Compensation still on the rise | Procedure kits recalled | A new definition of heart failure | Cardiologist named AHA president
New antiplatelet recommendations | Heart failure drug recalled | Imaging tech makes US debut | Conavi Medical's good news
Safety concerns lead to new recall | FDA approves surgical device | Parents in jail after obese son's death | A fraud warning
AI making an impact behind the scenes | New EARLY TAVR data | Americans keep poisoning themselves with semaglutide

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme